Media ReleasesImpediMed

View All ImpediMed News


ImpediMed's Share Purchase Plan Opens


The Share Purchase Plan (SPP) announced by ImpediMed Limited (ImpediMed or the Company) (ASX: IPD) on Wednesday, 27 October 2021 opens today. Eligible Shareholders in Australia and New Zealand now have the opportunity to apply for up to A$30,000 of new fully paid ordinary shares in ImpediMed (SPP Shares) without incurring brokerage, commissions, or other transaction costs.

The SPP follows ImpediMed’s successfully completed A$35 million institutional placement at an issue price of A$0.1525 per share (Placement).

Details of the SPP

Shareholders are eligible to participate in the SPP if, as at 7:00pm (AEDT) on Tuesday, 26 October 2021, they had a registered address in Australia or New Zealand (Eligible Shareholders).

The SPP is also being extended to Eligible Shareholders who are custodians to participate in the SPP on behalf of certain eligible beneficiaries on the terms and conditions set out in the SPP Booklet.

For more information, download the attached PDF.

Download this document

Are you a 708 sophisticated investor?

A sophisticated investor is defined under Section 708 of the Corporations Act (net assets of $2.5 million or annual incomes in excess of $250,000).

They are eligible to receive information regarding wholesale investment opportunities that are not available to regular or retail investors.

Please subscribe if you would like to be alerted to these types of opportunities.